Related scientific articles (all)

Y90 radioembolization of colorectal cancer liver metastases: response assessment by contrast-enhanced computed tomography with or without PET-CT guidance.

Authors : Vouche M, Salem R, Miller FH, Lemort M, Vanderlinden B, De Becker D, Hendlisz A, Flamen P
Year : 2015
Journal : Clin Imaging
Volume : 39(3)
Pages : 454-62

Neoadjuvant Therapy for Breast Cancer.

Authors : Zardavas D, Piccart-Gebhart M
Year : 2015
Journal : Annu. Rev. Med.
Volume : 66
Pages : 31-48

Chemotherapy treatment patterns and neutropenia management in gastric cancer.

Authors : Kalinka-Warzocha E, Plazas JG, Mineur L, Salek T, Hendlisz A, Decosta L, Vogl FD, Passalacqua R
Year : 2015
Journal : Gastric Cancer
Volume : 18(2)
Pages : 360-7

A proof of concept trial of the anti-EGFR antibody mixture Sym004 in patients with squamous cell carcinoma of the head and neck.

Authors : Machiels JP, Specenier P, Krauß J, Dietz A, Kaminsky MC, Lalami Y, Henke M, Keilholz U, Knecht R, Skartved NJ, Horak ID, Pamperin P, Braun S, Gauler TC
Year : 2015
Journal : Cancer Chemother Pharmacol
Volume : 76(1)
Pages : 13-20

Ambulatory Outpatient Management of patients with low risk febrile neutropaenia.

Authors : Cooksley T, Holland M, Klastersky J
Year : 2015
Journal : Acute Med
Volume : 14
Pages : 178-81

Pooled analysis of the surgical treatment for colorectal cancer liver metastases.

Authors : Veereman G, Robays J, Verleye L, Leroy R, Rolfo C, van Cutsem E, Bielen D, Ceelen W, Danse E, De Man M, Demetter P, Flamen P, Hendlisz A, Sinapi I, Vanbeckevoort D, Ysebaert D, Peeters M
Year : 2015
Journal : Crit Rev Oncol Hematol
Volume : 94(1)
Pages : 122-135

Next revolution in molecular theranostics: personalized medicine for urologic cancers.

Authors : Aoun F, Kourie HR, Artigas C, Roumeguère T
Year : 2015
Journal : Future Oncol
Volume : 11(15)
Pages : 2205-19

PIK3CA Mutations Are Associated With Decreased Benefit to Neoadjuvant Human Epidermal Growth Factor Receptor 2-Targeted Therapies in Breast Cancer.

Authors : Majewski IJ, Nuciforo P, Mittempergher L, Bosma AJ, Eidtmann H, Holmes E, Sotiriou C, Fumagalli D, Jimenez J, Aura C, Prudkin L, Díaz-Delgado MC, de la Peña L, Loi S, Ellis C, Schultz N, de Azambuja E, Harbeck N, Piccart-Gebhart M, Bernards R, Baselga J
Year : 2015
Journal : J. Clin. Oncol.
Volume : 33(12)
Pages : 1334-9

Optimal adjuvant treatment for patients with HER2-positive breast cancer in 2015.

Authors : Zardavas D, Fouad TM, Piccart-Gebhart M
Year : 2015
Journal : Breast
Volume : 24 Suppl 2
Pages : S143-8

Clinical management of breast cancer heterogeneity.

Authors : Zardavas D, Irrthum A, Swanton C, Piccart-Gebhart M
Year : 2015
Journal : Nat Rev Clin Oncol
Volume : 12(7)
Pages : 381-94

Phase III Open-Label Randomized Study of Eribulin Mesylate Versus Capecitabine in Patients With Locally Advanced or Metastatic Breast Cancer Previously Treated With an Anthracycline and a Taxane.

Authors : Kaufman PA, Awada A, Twelves C, Yelle L, Perez EA, Velikova G, Olivo MS, He Y, Dutcus CE, Cortes J
Year : 2015
Journal : J. Clin. Oncol.
Volume : 33(6)
Pages : 594-601

Aromatase inhibitors in male breast cancer: a pooled analysis.

Authors : Zagouri F, Sergentanis TN, Azim HA, Chrysikos D, Dimopoulos MA, Psaltopoulou T
Year : 2015
Journal : Breast Cancer Res. Treat.
Volume : 151(1)
Pages : 141-7

Pregnancy following breast cancer using assisted reproduction and its effect on long-term outcome.

Authors : Goldrat O, Kroman N, Peccatori FA, Cordoba O, Pistilli B, Lidegaard O, Demeestere I, Azim HA
Year : 2015
Journal : Eur. J. Cancer
Volume : 51(12)
Pages : 1490-6

Long-term hazard of recurrence in HER2+ breast cancer patients untreated with anti-HER2 therapy.

Authors : Strasser-Weippl K, Horick N, Smith IE, O Shaughnessy J, Ejlertsen B, Boyle F, Buzdar AU, Fumoleau P, Gradishar W, Martin M, Moy B, Piccart-Gebhart M, Pritchard KI, Lindquist D, Rappold E, Finkelstein DM, Goss PE
Year : 2015
Journal : Breast Cancer Res
Volume : 17(1)
Pages : 56

Harmonization of the evaluation of tumor infiltrating lymphocytes (TILs) in breast cancer: recommendations by an international TILs-working group 2014.

Authors : Salgado R, Denkert C, Demaria S, Sirtaine N, Klauschen F, Pruneri G, Wienert S, Van den Eynden G, Baehne FL, Penault-Llorca F, Perez EA, Thompson EA, Symmans WF, Richardson AL, Brock J, Criscitiello C, Bailey H, Ignatiadis M, Floris G, Sparano J, Kos Z, Nielsen T, Rimm DL, Allison KH, Reis-Filho JS, Loibl S, Sotiriou C, Viale G, Badve S, Adams S, Willard-Gallo K, Loi S
Year : 2015
Journal : Ann Oncol
Volume : 26(2)
Pages : 259-71

Exploring the safety of chemotherapy for treating breast cancer during pregnancy.

Authors : Lambertini M, Kamal NS, Peccatori FA, Del Mastro L, Azim HA
Year : 2015
Journal : Expert Opin Drug Saf
Volume : 14(9)
Pages : 1395-408

Uncovering the genomic heterogeneity of multifocal breast cancer.

Authors : Desmedt C, Fumagalli D, Pietri E, Zoppoli G, Brown D, Nik-Zainal S, Gundem G, Rothé F, Majjaj S, Garuti A, Carminati E, Loi S, Van Brussel T, Boeckx B, Maetens M, Mudie L, Vincent D, Kheddoumi N, Serra L, Massa I, Ballestrero A, Amadori D, Salgado R, de Wind A, Lambrechts D, Piccart-Gebhart M, Larsimont D, Campbell PJ, Sotiriou C
Year : 2015
Journal : J. Pathol.
Volume : 236(4)
Pages : 457-66

Optimising translational oncology in clinical practice: Strategies to accelerate progress in drug development.

Authors : Stahel R, Bogaerts J, Ciardiello F, De Ruysscher D, Dubsky P, Ducreux M, Finn S, Laurent-Puig P, Peters S, Piccart-Gebhart M, Smit E, Sotiriou C, Tejpar S, van Cutsem E, Tabernero J
Year : 2015
Journal : Cancer Treat Rev
Volume : 41(2)
Pages : 129-135

The Prognostic Significance of Metabolic Response Heterogeneity in Metastatic Colorectal Cancer.

Authors : Hendlisz A, Deleporte A, Delaunoit T, Maréchal R, Peeters M, Holbrechts S, Van den Eynde M, Houbiers G, Filleul B, Van Laethem JL, Ceyssens S, Barbuto AM, Lhommel R, Demolin G, Garcia C, El Mansy H, Ameye L, Moreau M, Guiot T, Paesmans M, Piccart-Gebhart M, Flamen P
Year : 2015
Journal : PLoS One
Volume : 10
Pages : e0138341

Disappearance of Upper Urinary Tract Urothelial Carcinoma after Treatment of a Borderline Brenner Tumor: Case Report and Literature Review.

Authors : Aoun F, Kourie HR, Sirtaine N, Hawaux E
Year : 2015
Journal : Oncol Res Treat
Volume : 38(7-8)
Pages : 379-81